487 related articles for article (PubMed ID: 17637477)
1. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
[TBL] [Abstract][Full Text] [Related]
3. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
[TBL] [Abstract][Full Text] [Related]
4. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
[TBL] [Abstract][Full Text] [Related]
6. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
7. Gold(III) compounds of 1,4,7-triazacyclononane showing high cytotoxicity against A-549 and HCT-116 tumor cell lines.
Shi P; Jiang Q; Lin J; Zhao Y; Lin L; Guo Z
J Inorg Biochem; 2006 May; 100(5-6):939-45. PubMed ID: 16472862
[TBL] [Abstract][Full Text] [Related]
8. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
9. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L
Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487
[TBL] [Abstract][Full Text] [Related]
11. Chemical behavior and in vitro activity of mixed phosphine gold(I) compounds on melanoma cell lines.
Caruso F; Pettinari C; Paduano F; Villa R; Marchetti F; Monti E; Rossi M
J Med Chem; 2008 Mar; 51(6):1584-91. PubMed ID: 18307291
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
[TBL] [Abstract][Full Text] [Related]
14. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
Hotze AC; van der Geer EP; Caspers SE; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
Inorg Chem; 2004 Aug; 43(16):4935-43. PubMed ID: 15285670
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study.
Castiñeiras A; Dehnen S; Fuchs A; García-Santos I; Sevillano P
Dalton Trans; 2009 Apr; (15):2731-9. PubMed ID: 19333496
[TBL] [Abstract][Full Text] [Related]
16. Solution chemistry and cytotoxic properties of novel organogold(III) compounds.
Messori L; Marcon G; Cinellu MA; Coronnello M; Mini E; Gabbiani C; Orioli P
Bioorg Med Chem; 2004 Dec; 12(23):6039-43. PubMed ID: 15519149
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure and cytotoxicity studies of four-coordinate bis (cis-bis(diphenylphosphino)ethene) gold(I) complexes, [Au(dppey)(2)]X.
Healy PC; Loughrey BT; Williams ML; Parsons PG
J Inorg Biochem; 2010 Jun; 104(6):625-31. PubMed ID: 20346516
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
20. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
